Ayana Pharma Signs Five Year MSA with Scinai Bioservices for Drug Development
Scinai Immunotherapeutics Ltd. has announced that Ayana Pharma Ltd. signed a five-year Master Service Agreement (MSA) with the company's CDMO business unit, Scinai Bioservices.
Scinai Immunotherapeutics | 09/04/2024 | By Aishwarya | 249
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy